Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies

BACKGROUND: Previous studies have reported the prognostic impact of primary tumor sidedness in metastatic colorectal cancer (mCRC) and its influence on cetuximab efficacy. The present retrospective analysis of two panitumumab trials investigated a possible association between tumor sidedness and tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Boeckx, N., Koukakis, R., Op de Beeck, K., Rolfo, C., Van Camp, G., Siena, S., Tabernero, J., Douillard, J.-Y., André, T., Peeters, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834073/
https://www.ncbi.nlm.nih.gov/pubmed/28449055
http://dx.doi.org/10.1093/annonc/mdx119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834073/
https://www.ncbi.nlm.nih.gov/pubmed/28449055
http://dx.doi.org/10.1093/annonc/mdx119

Ejemplares similares